title: Reversible constriction of the fetal ductus arteriosus after maternal use of topical diclofenac and methyl salicylate.
authors.forename: M R
authors.initials: MR
authors.lastname: Torloni
authors.forename: E
authors.initials: E
authors.lastname: Cordioli
authors.forename: M M
authors.initials: MM
authors.lastname: Zamith
authors.forename: W J
authors.initials: WJ
authors.lastname: Hisaba
authors.forename: L M M
authors.initials: LM
authors.lastname: Nardozza
authors.forename: R M
authors.initials: RM
authors.lastname: Santana
authors.forename: A F
authors.initials: AF
authors.lastname: Moron
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D003251:Constriction, Pathologic / Q000139:chemically induced; D004008:Diclofenac / Q000009:adverse effects*; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy*; D004452:Echocardiography; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced*; D005404:Fixatives / Q000009:adverse effects*; D006801:Humans; D011247:Pregnancy; D012459:Salicylates / Q000009:adverse effects*; D016216:Ultrasonography, Prenatal
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D005404:Fixatives; D012459:Salicylates; D004008:Diclofenac; C033069:methyl salicylate